Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Dianthus Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −16 vs. Q2 2023
- Shares held
- 10.1M
- +8.26M (+455.1%) vs. Q2 2023Converted for a 1-for-16 split
- Total value
- $136.3M
- +$114.3M (+519.3%) vs. Q2 2023
- New holders
- 9
- 8 more added
- Sold out
- 25
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Institutional & Family Asset Management, LLC | 3 | $41 | 0.00% | −0−4.0% | ReducedConverted for a 1-for-16 split |
| Qube Research & Technologies Ltd | 3 | $41 | 0.00% | +3 | New |
| JPMorgan Chase & Co | 41 | $560 | 0.00% | −3−6.7% | ReducedConverted for a 1-for-16 split |
| Wells Fargo & Company | 50 | $684 | 0.00% | +1+2.7% | AddedConverted for a 1-for-16 split |
| Bank of America Corp | 122 | $1.67K | 0.00% | −1,623−93.0% | ReducedConverted for a 1-for-16 split |
| Morgan Stanley | 155 | $2.12K | 0.00% | −899−85.3% | ReducedConverted for a 1-for-16 split |
| Royal Bank of Canada | 339 | $4.00K | 0.00% | −26−7.2% | ReducedConverted for a 1-for-16 split |
| UBS Group AG | 319 | $4.36K | 0.00% | −380−54.3% | ReducedConverted for a 1-for-16 split |
| Citigroup Inc | 3,868 | $52.9K | 0.00% | +3,868 | New |
| Jefferies Financial Group Inc. | 13,200 | $180.4K | 0.00% | +13,200 | New |
| Bessemer Group Inc | 14,829 | $203.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-16 split |
| RBF Capital, LLC | 15,676 | $214.3K | 0.01% | 00.0% | UnchangedConverted for a 1-for-16 split |
| ArrowMark Colorado Holdings LLC | 20,788 | $284.2K | 0.00% | +20,788 | New |
| Acadian Asset Management LLC | 22,299 | $303.0K | 0.00% | −6,307−22.0% | ReducedConverted for a 1-for-16 split |
| Geode Capital Management, LLC | 26,341 | $360.2K | 0.00% | +3,985+17.8% | AddedConverted for a 1-for-16 split |
| BlackRock Inc. | 32,151 | $439.5K | 0.00% | +9,391+41.3% | AddedConverted for a 1-for-16 split |
| Renaissance Technologies LLC | 35,216 | $481.0K | 0.00% | +5,110+17.0% | AddedConverted for a 1-for-16 split |
| Laurion Capital Management LP | 36,393 | $497.5K | 0.01% | 00.0% | UnchangedConverted for a 1-for-16 split |
| Citadel Advisors LLC | 105,561 | $1.44M | 0.00% | −104,439−49.7% | ReducedConverted for a 1-for-16 split |
| Vanguard Group Inc | 126,877 | $1.73M | 0.00% | +3,851+3.1% | AddedConverted for a 1-for-16 split |
| Alphabet Inc. | 208,697 | $2.85M | 0.18% | 00.0% | UnchangedConverted for a 1-for-16 split |
| Atlas Venture Life Science Advisors, LLC | 236,979 | $3.24M | 0.50% | 00.0% | UnchangedConverted for a 1-for-16 split |
| Nantahala Capital Management, LLC | 336,862 | $4.60M | 0.58% | +24,362+7.8% | AddedConverted for a 1-for-16 split |
| Octagon Capital Advisors LP | 480,000 | $6.56M | 1.16% | +445,625+1,296.4% | AddedConverted for a 1-for-16 split |
| Tang Capital Management LLC | 591,636 | $8.09M | 1.14% | +212,886+56.2% | AddedConverted for a 1-for-16 split |
| VR Adviser, LLC | 927,706 | $12.7M | 1.33% | +927,706 | New |
| Avidity Partners Management LP | 1,217,554 | $16.6M | 0.67% | +1,217,554 | New |
| 5AM Venture Management, LLC | 1,472,264 | $20.1M | 5.79% | +1,472,264 | New |
| Fairmount Funds Management LLC | 1,928,503 | $26.4M | 3.17% | +1,928,503 | New |
| FMR LLC | 2,218,212 | $29.0M | 0.00% | +2,218,212 | New |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −23,642−100.0% | Sold outConverted for a 1-for-16 split |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −20,788−100.0% | Sold outConverted for a 1-for-16 split |
| Leonteq Securities AG | 0 | $0 | 0.00% | −12,500−100.0% | Sold outConverted for a 1-for-16 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,088−100.0% | Sold outConverted for a 1-for-16 split |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −10,466−100.0% | Sold outConverted for a 1-for-16 split |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,331−100.0% | Sold outConverted for a 1-for-16 split |
| State Street Corp | 0 | $0 | 0.00% | −8,700−100.0% | Sold outConverted for a 1-for-16 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −7,517−100.0% | Sold outConverted for a 1-for-16 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −6,456−100.0% | Sold outConverted for a 1-for-16 split |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −6,250−100.0% | Sold outConverted for a 1-for-16 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,466−100.0% | Sold outConverted for a 1-for-16 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −3,775−100.0% | Sold outConverted for a 1-for-16 split |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −2,948−100.0% | Sold outConverted for a 1-for-16 split |
| Fiduciary Trust Co | 0 | $0 | 0.00% | −1,910−100.0% | Sold outConverted for a 1-for-16 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,711−100.0% | Sold outConverted for a 1-for-16 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,683−100.0% | Sold outConverted for a 1-for-16 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −762−100.0% | Sold outConverted for a 1-for-16 split |
| Sound View Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −656−100.0% | Sold outConverted for a 1-for-16 split |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −625−100.0% | Sold outConverted for a 1-for-16 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −280−100.0% | Sold outConverted for a 1-for-16 split |
| Umb Bank N A | 0 | $0 | 0.00% | −46−100.0% | Sold outConverted for a 1-for-16 split |
| Allworth Financial LP | 0 | $0 | 0.00% | −23−100.0% | Sold outConverted for a 1-for-16 split |
| Barclays PLC | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-16 split |
| Pension & Wealth Management Advisors, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-16 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-16 split |